Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Table of Contents

September 01, 2005; Volume 33,Issue 9

Articles

  • You have access
    ENANTIOSELECTIVE METABOLISM AND CYTOTOXICITY OF R-IFOSFAMIDE AND S-IFOSFAMIDE BY TUMOR CELL-EXPRESSED CYTOCHROMES P450
    Chong-Sheng Chen, Youssef Jounaidi and David J. Waxman
    Drug Metabolism and Disposition September 2005, 33 (9) 1261-1267; DOI: https://doi.org/10.1124/dmd.105.004788
  • You have access
    POPULATION PHARMACOKINETICS OF CYCLOSPORINE IN CLINICAL RENAL TRANSPLANT PATIENTS
    Ke-Hua Wu, Yi-Min Cui, Jin-Feng Guo, Ying Zhou, Suo-Di Zhai, Fu-De Cui and Wei Lu
    Drug Metabolism and Disposition September 2005, 33 (9) 1268-1275; DOI: https://doi.org/10.1124/dmd.105.004358
  • You have access
    REGULATION OF MOUSE ORGANIC ANION-TRANSPORTING POLYPEPTIDES (OATPS) IN LIVER BY PROTOTYPICAL MICROSOMAL ENZYME INDUCERS THAT ACTIVATE DISTINCT TRANSCRIPTION FACTOR PATHWAYS
    Xingguo Cheng, Jonathan Maher, Matthew Z. Dieter and Curtis D. Klaassen
    Drug Metabolism and Disposition September 2005, 33 (9) 1276-1282; DOI: https://doi.org/10.1124/dmd.105.003988
  • You have access
    EFFECT OF CYP2D6*10 ALLELE ON THE PHARMACOKINETICS OF LORATADINE IN CHINESE SUBJECTS
    Ophelia Q. P. Yin, X. J. Shi, B. Tomlinson and Moses S. S. Chow
    Drug Metabolism and Disposition September 2005, 33 (9) 1283-1287; DOI: https://doi.org/10.1124/dmd.105.005025
  • You have access
    ACCURACY OF ALLOMETRICALLY PREDICTED PHARMACOKINETIC PARAMETERS IN HUMANS: ROLE OF SPECIES SELECTION
    Huadong Tang and Michael Mayersohn
    Drug Metabolism and Disposition September 2005, 33 (9) 1288-1293; DOI: https://doi.org/10.1124/dmd.105.004127
  • You have access
    A MATHEMATICAL DESCRIPTION OF THE FUNCTIONALITY OF CORRECTION FACTORS USED IN ALLOMETRY FOR PREDICTING HUMAN DRUG CLEARANCE
    Huadong Tang and Michael Mayersohn
    Drug Metabolism and Disposition September 2005, 33 (9) 1294-1296; DOI: https://doi.org/10.1124/dmd.105.004135
  • You have access
    A NOVEL MODEL FOR PREDICTION OF HUMAN DRUG CLEARANCE BY ALLOMETRIC SCALING
    Huadong Tang and Michael Mayersohn
    Drug Metabolism and Disposition September 2005, 33 (9) 1297-1303; DOI: https://doi.org/10.1124/dmd.105.004143
  • You have access
    A UNIFIED MODEL FOR PREDICTING HUMAN HEPATIC, METABOLIC CLEARANCE FROM IN VITRO INTRINSIC CLEARANCE DATA IN HEPATOCYTES AND MICROSOMES
    Robert J. Riley, D. F. McGinnity and R. P. Austin
    Drug Metabolism and Disposition September 2005, 33 (9) 1304-1311; DOI: https://doi.org/10.1124/dmd.105.004259
  • You have access
    INVOLVEMENT OF MOLYBDENUM HYDROXYLASES IN REDUCTIVE METABOLISM OF NITRO POLYCYCLIC AROMATIC HYDROCARBONS IN MAMMALIAN SKIN
    Osamu Ueda, Kazumi Sugihara, Shigeru Ohta and Shigeyuki Kitamura
    Drug Metabolism and Disposition September 2005, 33 (9) 1312-1318; DOI: https://doi.org/10.1124/dmd.105.005306
  • You have access
    DIRECT DETERMINATION OF UNBOUND INTRINSIC DRUG CLEARANCE IN THE MICROSOMAL STABILITY ASSAY
    Claudio Giuliano, Mark Jairaj, Christian M. Zafiu and Ralph Laufer
    Drug Metabolism and Disposition September 2005, 33 (9) 1319-1324; DOI: https://doi.org/10.1124/dmd.105.005033
  • You have access
    THE USE OF SANDWICH-CULTURED RAT HEPATOCYTES TO DETERMINE THE INTRINSIC CLEARANCE OF COMPOUNDS WITH DIFFERENT EXTRACTION RATIOS: 7-ETHOXYCOUMARIN AND WARFARIN
    Nicoline Treijtel, Hanneke van Helvoort, Arjan Barendregt, Bas J. Blaauboer and Jan C. H. van Eijkeren
    Drug Metabolism and Disposition September 2005, 33 (9) 1325-1332; DOI: https://doi.org/10.1124/dmd.105.004390
  • You have access
    EXPRESSION OF HUMAN PHASE II ENZYMES IN CHIMERIC MICE WITH HUMANIZED LIVER
    Miki Katoh, Tomohito Matsui, Hirotoshi Okumura, Miki Nakajima, Masuhiro Nishimura, Shinsaku Naito, Chise Tateno, Katsutoshi Yoshizato and Tsuyoshi Yokoi
    Drug Metabolism and Disposition September 2005, 33 (9) 1333-1340; DOI: https://doi.org/10.1124/dmd.105.005157
  • You have access
    SULFONATION OF ENVIRONMENTAL CHEMICALS AND THEIR METABOLITES IN THE POLAR BEAR (Ursus maritimus)
    James C. Sacco and Margaret O. James
    Drug Metabolism and Disposition September 2005, 33 (9) 1341-1348; DOI: https://doi.org/10.1124/dmd.105.004648
  • You have access
    UDP-GLUCURONOSYLTRANSFERASE 2B7 IS THE MAJOR ENZYME RESPONSIBLE FOR GEMCABENE GLUCURONIDATION IN HUMAN LIVER MICROSOMES
    Jonathan N. Bauman, Theunis C. Goosen, Meera Tugnait, Vincent Peterkin, Susan I. Hurst, Lee C. Menning, Mark Milad, Michael H. Court and J. Andrew Williams
    Drug Metabolism and Disposition September 2005, 33 (9) 1349-1354; DOI: https://doi.org/10.1124/dmd.105.005108
  • You have access
    CANALICULAR AND SINUSOIDAL DISPOSITION OF BILIRUBIN MONO- AND DIGLUCURONIDES IN SANDWICH-CULTURED HUMAN AND RAT PRIMARY HEPATOCYTES
    György Lengyel, Zsuzsa Veres, Pál Szabó, László Vereczkey and Katalin Jemnitz
    Drug Metabolism and Disposition September 2005, 33 (9) 1355-1360; DOI: https://doi.org/10.1124/dmd.105.004481
  • You have access
    CYP2A6 IS A PRINCIPAL ENZYME INVOLVED IN HYDROXYLATION OF 1,7-DIMETHYLXANTHINE, A MAIN CAFFEINE METABOLITE, IN HUMANS
    Miyuki Kimura, Hiroshi Yamazaki, Masaki Fujieda, Kazuma Kiyotani, Goro Honda, Junji Saruwatari, Kazuko Nakagawa, Takashi Ishizaki and Tetsuya Kamataki
    Drug Metabolism and Disposition September 2005, 33 (9) 1361-1366; DOI: https://doi.org/10.1124/dmd.105.004796
  • You have access
    METABOLISM OF THE ONE-RING OPEN METABOLITES OF THE CARDIOPROTECTIVE DRUG DEXRAZOXANE TO ITS ACTIVE METAL-CHELATING FORM IN THE RAT
    Patricia E. Schroeder and Brian B. Hasinoff
    Drug Metabolism and Disposition September 2005, 33 (9) 1367-1372; DOI: https://doi.org/10.1124/dmd.105.005546
  • You have access
    METABOLISM AND DISPOSITION OF A POTENT GROUP II METABOTROPIC GLUTAMATE RECEPTOR AGONIST, IN RATS, DOGS, AND MONKEYS
    Joyce K. James, Masato Nakamura, Atsuro Nakazato, Kanyin E. Zhang, Merryl Cramer, Janice Brunner, Jacquelynn Cook and Weichao G. Chen
    Drug Metabolism and Disposition September 2005, 33 (9) 1373-1381; DOI: https://doi.org/10.1124/dmd.105.004978
  • You have access
    BIMOLECULAR FLUORESCENCE COMPLEMENTATION ANALYSIS OF CYTOCHROME P450 2C2, 2E1, AND NADPH-CYTOCHROME P450 REDUCTASE MOLECULAR INTERACTIONS IN LIVING CELLS
    Cengiz Ozalp, Elzbieta Szczesna-Skorupa and Byron Kemper
    Drug Metabolism and Disposition September 2005, 33 (9) 1382-1390; DOI: https://doi.org/10.1124/dmd.105.005538
  • You have access
    ISOFORM-SPECIFIC EXPRESSION AND INDUCTION OF UDP-GLUCURONOSYLTRANSFERASE IN IMMUNOACTIVATED PERITONEAL MACROPHAGES OF THE RAT
    Yuki Tochigi, Naoko Yamashiki, Satoru Ohgiya, Sawako Ganaha and Hiroshi Yokota
    Drug Metabolism and Disposition September 2005, 33 (9) 1391-1398; DOI: https://doi.org/10.1124/dmd.105.004879

Accelerated Communication

  • You have access
    QUANTITATIVE ANALYSIS OF CYTOCHROME P450 ISOZYMES BY MEANS OF UNIQUE ISOZYME-SPECIFIC TRYPTIC PEPTIDES: A PROTEOMIC APPROACH
    Michail A. Alterman, Boris Kornilayev, Tatyana Duzhak and Dmitry Yakovlev
    Drug Metabolism and Disposition September 2005, 33 (9) 1399-1407; DOI: https://doi.org/10.1124/dmd.105.004812
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 33 (9)
Drug Metabolism and Disposition
Vol. 33, Issue 9
1 Sep 2005
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts

Jump to

  • Articles
  • Accelerated Communication
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics